Clinical Trials · NCT00805935
Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 110
- Start date
- Jan 2009
- Locations
- 6 sites, United States
- Primary endpoint
- Participants With Cycle Cancellation Due to Risk of Ovarian Hyperstimulation Syndrome (OHSS) Between Weeks 1 - 3